HEPHAISTOS-Pharma raised €4.5 million in a seed round led by Elaia to develop next-gen immunostimulants against cancer
Amount Raised
€4.5 Million
Round Type
Seed
OrsayBiotechnologyInvestors
Description
HEPHAISTOS-Pharma has completed its €4.5 million seed round to finance industrialization and advance its lead candidate ONCO-Boost towards the clinic. The round will mainly finance the industrialization of drug production and regulatory toxicity studies to file for the CTA in Europe, as well as generate new additional data in monotherapy against unmet medical needs and in combination with promising drugs from other pharmaceutical companies.
Quick answer
HEPHAISTOS-Pharma raised €4.5 Million in a Seed round, dated May 16, 2024. Investors: Noshaq, Fondation Fournier Majoie, Xista Science Ventures and Elaia. HEPHAISTOS-Pharma is based in Orsay, Ile De France, France.
- How much did HEPHAISTOS-Pharma raise?
- HEPHAISTOS-Pharma raised €4.5 Million in a Seed round on May 16, 2024.
- Who invested in HEPHAISTOS-Pharma?
- Noshaq, Fondation Fournier Majoie, Xista Science Ventures and Elaia are named as investors in this round.
- What does HEPHAISTOS-Pharma do?
- HEPHAISTOS-Pharma is a biotechnology startup developing anti-tumor immunotherapies to revolutionize cancer treatments by increasing the effectiveness of monoclonal antibodies and enabling the treatment of incurable..
- Where is HEPHAISTOS-Pharma based and how big is it?
- HEPHAISTOS-Pharma is based in Orsay, Ile De France, France.
- Who are the decision-makers at HEPHAISTOS-Pharma?
- Fundz holds 1 contact at HEPHAISTOS-Pharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as HEPHAISTOS-Pharma that raised within 45 days of this round, from Fundz verified event records.
- Aspira Women’s Health raised $1.9M on June 30, 2024.
- TMRW Life Sciences raised $28M on June 28, 2024.
- Kala raised $12M on June 28, 2024.
- Waypoint Bio raised $15M (Seed) on June 28, 2024.
- DiaMedica Therapeutics raised $12M on June 28, 2024.
- Phlow raised $5M on June 28, 2024.
Who to call at HEPHAISTOS-Pharma, and when
A new round usually means HEPHAISTOS-Pharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day HEPHAISTOS-Pharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HEPHAISTOS-Pharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HEPHAISTOS-Pharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HEPHAISTOS-Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
HEPHAISTOS-Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.